Update on world health organization HIV drug resistance prevention and assessment strategy: 2004-2011

M. R. Jordan, D. E. Bennett, M. A. Wainberg, D. Havlir, S. Hammer, C. Yang, L. Morris, M. Peeters, A. M. Wensing, N. Parkin, J. B. Nachega, A. Phillips, A. De Luca, E. Geng, A. Calmy, E. Raizes, P. Sandstrom, C. P. Archibald, J. Perriëns, C. M. McClureS. Y. Hong, J. H. McMahon, N. Dedes, D. Sutherland, S. Bertagnolio

Research output: Contribution to journalArticle

Abstract

The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

Original languageEnglish (US)
JournalClinical Infectious Diseases
Volume54
Issue numberSUPPL. 4
DOIs
StatePublished - May 15 2012

Fingerprint

Drug Resistance
HIV
United Nations
Acquired Immunodeficiency Syndrome
Joints

ASJC Scopus subject areas

  • Infectious Diseases
  • Microbiology (medical)

Cite this

Jordan, M. R., Bennett, D. E., Wainberg, M. A., Havlir, D., Hammer, S., Yang, C., ... Bertagnolio, S. (2012). Update on world health organization HIV drug resistance prevention and assessment strategy: 2004-2011. Clinical Infectious Diseases, 54(SUPPL. 4). https://doi.org/10.1093/cid/cis206

Update on world health organization HIV drug resistance prevention and assessment strategy : 2004-2011. / Jordan, M. R.; Bennett, D. E.; Wainberg, M. A.; Havlir, D.; Hammer, S.; Yang, C.; Morris, L.; Peeters, M.; Wensing, A. M.; Parkin, N.; Nachega, J. B.; Phillips, A.; De Luca, A.; Geng, E.; Calmy, A.; Raizes, E.; Sandstrom, P.; Archibald, C. P.; Perriëns, J.; McClure, C. M.; Hong, S. Y.; McMahon, J. H.; Dedes, N.; Sutherland, D.; Bertagnolio, S.

In: Clinical Infectious Diseases, Vol. 54, No. SUPPL. 4, 15.05.2012.

Research output: Contribution to journalArticle

Jordan, MR, Bennett, DE, Wainberg, MA, Havlir, D, Hammer, S, Yang, C, Morris, L, Peeters, M, Wensing, AM, Parkin, N, Nachega, JB, Phillips, A, De Luca, A, Geng, E, Calmy, A, Raizes, E, Sandstrom, P, Archibald, CP, Perriëns, J, McClure, CM, Hong, SY, McMahon, JH, Dedes, N, Sutherland, D & Bertagnolio, S 2012, 'Update on world health organization HIV drug resistance prevention and assessment strategy: 2004-2011', Clinical Infectious Diseases, vol. 54, no. SUPPL. 4. https://doi.org/10.1093/cid/cis206
Jordan, M. R. ; Bennett, D. E. ; Wainberg, M. A. ; Havlir, D. ; Hammer, S. ; Yang, C. ; Morris, L. ; Peeters, M. ; Wensing, A. M. ; Parkin, N. ; Nachega, J. B. ; Phillips, A. ; De Luca, A. ; Geng, E. ; Calmy, A. ; Raizes, E. ; Sandstrom, P. ; Archibald, C. P. ; Perriëns, J. ; McClure, C. M. ; Hong, S. Y. ; McMahon, J. H. ; Dedes, N. ; Sutherland, D. ; Bertagnolio, S. / Update on world health organization HIV drug resistance prevention and assessment strategy : 2004-2011. In: Clinical Infectious Diseases. 2012 ; Vol. 54, No. SUPPL. 4.
@article{ba5e9d85fa2f478ea99a5246892cce6a,
title = "Update on world health organization HIV drug resistance prevention and assessment strategy: 2004-2011",
abstract = "The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.",
author = "Jordan, {M. R.} and Bennett, {D. E.} and Wainberg, {M. A.} and D. Havlir and S. Hammer and C. Yang and L. Morris and M. Peeters and Wensing, {A. M.} and N. Parkin and Nachega, {J. B.} and A. Phillips and {De Luca}, A. and E. Geng and A. Calmy and E. Raizes and P. Sandstrom and Archibald, {C. P.} and J. Perri{\"e}ns and McClure, {C. M.} and Hong, {S. Y.} and McMahon, {J. H.} and N. Dedes and D. Sutherland and S. Bertagnolio",
year = "2012",
month = "5",
day = "15",
doi = "10.1093/cid/cis206",
language = "English (US)",
volume = "54",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL. 4",

}

TY - JOUR

T1 - Update on world health organization HIV drug resistance prevention and assessment strategy

T2 - 2004-2011

AU - Jordan, M. R.

AU - Bennett, D. E.

AU - Wainberg, M. A.

AU - Havlir, D.

AU - Hammer, S.

AU - Yang, C.

AU - Morris, L.

AU - Peeters, M.

AU - Wensing, A. M.

AU - Parkin, N.

AU - Nachega, J. B.

AU - Phillips, A.

AU - De Luca, A.

AU - Geng, E.

AU - Calmy, A.

AU - Raizes, E.

AU - Sandstrom, P.

AU - Archibald, C. P.

AU - Perriëns, J.

AU - McClure, C. M.

AU - Hong, S. Y.

AU - McMahon, J. H.

AU - Dedes, N.

AU - Sutherland, D.

AU - Bertagnolio, S.

PY - 2012/5/15

Y1 - 2012/5/15

N2 - The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

AB - The HIV drug resistance (HIVDR) prevention and assessment strategy, developed by the World Health Organization (WHO) in partnership with HIVResNet, includes monitoring of HIVDR early warning indicators, surveys to assess acquired and transmitted HIVDR, and development of an accredited HIVDR genotyping laboratory network to support survey implementation in resource-limited settings. As of June 2011, 52 countries had implemented at least 1 element of the strategy, and 27 laboratories had been accredited. As access to antiretrovirals expands under the WHO/Joint United Nations Programme on HIV/AIDS Treatment 2.0 initiative, it is essential to strengthen HIVDR surveillance efforts in the face of increasing concern about HIVDR emergence and transmission.

UR - http://www.scopus.com/inward/record.url?scp=84860368504&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860368504&partnerID=8YFLogxK

U2 - 10.1093/cid/cis206

DO - 10.1093/cid/cis206

M3 - Article

C2 - 22544182

AN - SCOPUS:84860368504

VL - 54

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - SUPPL. 4

ER -